Medication safety in residential aged-care facilities: a perspective

被引：19

作者：

Wilson, Nicholas M. ^{[2
,3
]}

March, Lyn M. ^{[2
,3
]}

Sambrook, Philip N. ^{[2
,3
]}

Hilmer, Sarah N. ^{[1
,2
]}

机构：

[1] Royal North Shore Hosp, St Leonards, NSW 2065, Australia

[2] Univ Sydney, Sydney Med Sch, Camperdown, NSW 2006, Australia

[3] Royal North Shore Hosp, Inst Bone & Joint Res, Kolling Inst Med Res, St Leonards, NSW 2065, Australia

来源：

THERAPEUTIC ADVANCES IN DRUG SAFETY | 2010年 / 1卷 / 01期

关键词：

inappropriate medications; medication safety; nursing home; pharmacist review; residential aged care;

D O I：

10.1177/2042098610381418

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Medication safety must be tailored to the distinctive issues in residential aged-care facilities (RACFs). The health and functional characteristics of their residents are different to those of hospital inpatients and community-dwelling older adults, and there are unique staffing and management issues. Understanding the aetiology and epidemiology of drug-related problems is vital in developing methods to improve patient safety. In this perspective review, we discuss tools that are used to quantify exposure to 'high-risk' medications and their evaluation in residential aged-care settings. Drug withdrawal interventions are described as a potential way to reduce adverse drug events in RACFs. Multidisciplinary professional interventions, education programs and improved communication between health professionals have been shown to improve medication safety in RACFs. Technological advances and other administrative strategies may also improve resident safety. This perspective addresses issues in medication safety facing RACFs and methods to improve the safety of medicines for their residents.

引用

页码：11 / 20

页数：10

共 100 条

[11] Central nervous system medication use and incident mobility limitation in community elders: the health, aging, and body composition study [J].

Boudreau, Robert M. ;

Hanlon, Joseph T. ;

Roumani, Yazan F. ;

Studenski, Stephanie A. ;

Ruby, Christine M. ;

Wright, Rollin M. ;

Hilmer, Sarah N. ;

Shorr, Ronald I. ;

Bauer, Douglas C. ;

Simonsick, Eleanor M. ;

Newman, Anne B. .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (10) :916-922

[12]

Bureau of Health Professions, 2010, STAT MICH DEP COMM H

[13] Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women [J].

Cao, Y-J ;

Mager, D. E. ;

Simonsick, E. M. ;

Hilmer, S. N. ;

Ling, S. M. ;

Windham, B. G. ;

Crentsil, V. ;

Yasar, S. ;

Fried, L. P. ;

Abernethy, D. R. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (03) :422-429

[14] The anticholinergic drug scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity [J].

Carnahan, Ryan M. ;

Lund, Brian C. ;

Perry, Paul J. ;

Pollock, Bruce G. ;

Culp, Kennith R. .

JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (12) :1481-1486

[15]

Carnahan Ryan M, 2002, Psychopharmacol Bull, V36, P14

[16] Targeting Suboptimal Prescribing in the Elderly: A Review of the Impact of Pharmacy Services [J].

Castelino, Ronald L. ;

Bajorek, Beata V. ;

Chen, Timothy F. .

ANNALS OF PHARMACOTHERAPY, 2009, 43 (06) :1096-1106

[17]

Catania P N, 1998, Home Care Provid, V3, P20, DOI 10.1016/S1084-628X(98)90150-2

[18]

Catania P.N., 1998, HOME CARE PROVID, V3, P24

[19]

Christensen Dale, 2004, Am J Geriatr Pharmacother, V2, P248, DOI 10.1016/j.amjopharm.2004.12.002

[20] Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home - A controlled, double-blind study [J].

Cohen-Mansfield, J ;

Lipson, S ;

Werner, P ;

Billig, N ;

Taylor, L ;

Woosley, R .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (15) :1733-1740

← 1 2 3 4 5 6 7 8 9 10 →